CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis

[1]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling by ITAM-associated receptors , 2009, Nature Immunology.

[2]  W. Wu,et al.  Expansion of CD14+CD16+ peripheral monocytes among patients with aseptic loosening , 2009, Inflammation Research.

[3]  J. Hamilton,et al.  The proliferative human monocyte subpopulation contains osteoclast precursors , 2009, Arthritis research & therapy.

[4]  J. Reuben,et al.  PI3K limits TNF‐α production in CD16‐activated monocytes , 2009, European journal of immunology.

[5]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[6]  S. Gordon,et al.  Essential Role of DAP12 Signaling in Macrophage Programming into a Fusion-Competent State , 2008, Science Signaling.

[7]  M. Benhamou,et al.  Inhibitory ITAMs: a matter of life and death. , 2008, Trends in immunology.

[8]  E. Schwarz,et al.  VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism* , 2008, Journal of Biological Chemistry.

[9]  I. Mikhailenko,et al.  IL‐4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6‐dependent, homotypic mechanism: contribution of E‐cadherin , 2007, Journal of leukocyte biology.

[10]  L. Ziegler‐Heitbrock,et al.  Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome. , 2007, Arthritis and rheumatism.

[11]  I. Velasco,et al.  CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation , 2007, Nature Medicine.

[12]  D. Mosser,et al.  Monocyte subpopulations and their differentiation patterns during infection , 2007, Journal of leukocyte biology.

[13]  N. Takeyama,et al.  Selective expansion of the CD14+/CD16bright subpopulation of circulating monocytes in patients with hemophagocytic syndrome , 2007, Annals of Hematology.

[14]  H. Makino,et al.  Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients. , 2007, Acta medica Okayama.

[15]  L. Ziegler‐Heitbrock,et al.  The CD14+ CD16+ blood monocytes: their role in infection and inflammation , 2007, Journal of leukocyte biology.

[16]  Jianbin Wang,et al.  CD16+ monocytes produce IL‐6, CCL2, and matrix metalloproteinase‐9 upon interaction with CX3CL1‐expressing endothelial cells , 2006, Journal of leukocyte biology.

[17]  N. Miyasaka,et al.  Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts , 2006, Arthritis research & therapy.

[18]  E. Schwarz,et al.  Autoimmunity and Bone , 2006, Annals of the New York Academy of Sciences.

[19]  L. Lanier,et al.  Role of ITAM‐containing adapter proteins and their receptors in the immune system and bone , 2005, Immunological reviews.

[20]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[21]  D. Kane,et al.  Early psoriatic arthritis. , 2005, Rheumatic diseases clinics of North America.

[22]  L. Lanier,et al.  TREM2, a DAP12‐Associated Receptor, Regulates Osteoclast Differentiation and Function , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  D. F. Barber,et al.  PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus , 2005, Nature Medicine.

[24]  J. Hamilton,et al.  Regulation of Toll‐like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis‐related antigens , 2005, Clinical and experimental immunology.

[25]  T. Taniguchi,et al.  Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis , 2004, Nature.

[26]  L. Lanier,et al.  The Signaling Adapter Protein DAP12 Regulates Multinucleation During Osteoclast Development , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  S. Teitelbaum,et al.  Genetic regulation of osteoclast development and function , 2003, Nature Reviews Genetics.

[28]  F. Luscinskas,et al.  Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes , 2003, The Journal of experimental medicine.

[29]  E. Schwarz,et al.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. , 2003, The Journal of clinical investigation.

[30]  K. Schäkel,et al.  The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting , 2002, The Journal of experimental medicine.

[31]  T. Espevik,et al.  The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF1 , 2002, The Journal of Immunology.

[32]  D. Elewaut,et al.  Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[33]  C. Langlet,et al.  Membrane rafts and signaling by the multichain immune recognition receptors. , 2000, Current opinion in immunology.

[34]  J. Scherberich,et al.  Expanded CD14+ CD16+Monocyte Subpopulation in Patients with Acute and Chronic Infections Undergoing Hemodialysis , 1998, Infection and Immunity.

[35]  H. Ziegler-Heitbrock,et al.  Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. , 1996, Immunology today.

[36]  B. Passlick,et al.  The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients , 1993 .

[37]  B. Perussia.  Fc receptors on natural killer cells. , 1998, Current topics in microbiology and immunology.

[38]  B. Passlick,et al.  The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. , 1993, Blood.

[39]  W. Eyler,et al.  PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.